Observations placeholder
Alvesco
Identifier
017985
Type of Spiritual Experience
Background
A description of the experience
Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada. Phase 3 trials for the hay fever indication outside of the US are ongoing. The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006. Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings
On Sep, 26, 2015: 981 people reported to have side effects when taking Alvesco. Among them, 6 people (0.61%) have Death.
Time on Alvesco when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death100.00%0.00%0.00%0.00%0.00%0.00%0.00%
On Dec, 19, 2016 1,969 people reported to have side effects when taking Alvesco.
Among them, 10 people (0.51%) have Hallucinations
Time on Alvesco when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Alvesco :
Female | Male | |
Hallucination | 71.43% | 28.57% |
Age of people who have Hallucination when taking Alvesco :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 14.29% | 0.00% | 0.00% | 0.00% | 0.00% | 71.43% | 14.29% |